Study Cohort
Patients (n=63) diagnosed with SARS-CoV-2 infection by Real-Time PCR
from respiratory specimens (Altona Diagnostics, Hamburg, Germany) were
enrolled into the study at Marburg University Hospital (Germany) between
March and November 2020. The baseline characteristics of the study
population are shown in Table S1.